The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.
Ontology highlight
ABSTRACT: Classic hallucinogens share pharmacology as serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptor agonists. Unique among most other Schedule 1 drugs, they are generally non-addictive and can be effective tools in the treatment of addiction. Mechanisms underlying these attributes are largely unknown. However, many preclinical studies show that 5-HT2C agonists counteract the addictive effects of drugs from several classes, suggesting this pharmacological property of classic hallucinogens may be significant. Drawing from a comprehensive analysis of preclinical behavior, neuroanatomy, and neurochemistry studies, this review builds rationale for this hypothesis, and also proposes a testable, neurobiological framework. 5-HT2C agonists work, in part,
SUBMITTER: Canal CE
PROVIDER: S-EPMC5445387 | biostudies-literature | 2017 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA